Anti-HECT E3 ubiquitin ligase antibody (ab90146)

Overview

  • Product nameAnti-HECT E3 ubiquitin ligase antibody
    See all HECT E3 ubiquitin ligase primary antibodies
  • Description
    Rabbit polyclonal to HECT E3 ubiquitin ligase
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Cow
  • Immunogen

    Synthetic peptide corresponding to a region within N terminal amino acids 288-337 (LVAELVGYRV TQIACGRWHT LAYVSDLGKV FSFGSGKDGQ LGNGGTRDQL) of Human HECT E3 ubiquitin ligase (NP_057407).

  • Positive control
    • HT1080 cell lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab90146 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 117 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.

Target

  • FunctionMajor E3 ligase for ISG15 conjugation. Acts as a positive regulator of innate antiviral response in cells induced by interferon. Makes part of the ISGylation machinery that recognizes target proteins in a broad and relatively non-specific manner. Catalyzes ISGylation of IRF3 which results in sustained activation, it attenuates IRF3-PIN1 interaction, which antagonizes IRF3 ubiquitination and degradation, and boosts the antiviral response. Catalyzes ISGylation of influenza A viral NS1 which attenuates virulence; ISGylated NS1 fails to form homodimers and thus to interact with its RNA targets. Catalyzes ISGylation of papillomavirus type 16 L1 protein which results in dominant-negative effect on virus infectivity. Physically associated with polyribosomes, broadly modifies newly synthesized proteins in a cotranslational manner. In an interferon-stimulated cell, newly translated viral proteins are primary targets of ISG15.
  • Tissue specificityExpressed in testis and to a lesser degree in brain, ovary and placenta. Found in most tissues at low levels.
  • Sequence similaritiesContains 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain.
    Contains 5 RCC1 repeats.
  • Post-translational
    modifications
    ISGylated.
  • Cellular localizationCytoplasm > perinuclear region. Associated with the polyribosomes, probably via the 60S subunit.
  • Information by UniProt
  • Database links
  • Alternative names
    • CEB1 antibody
    • CEBP1 antibody
    • Cyclin E binding protein 1 antibody
    • Cyclin-E-binding protein 1 antibody
    • E3 ISG15--protein ligase HERC5 antibody
    • HECT domain and RCC1 like domain containing protein 5 antibody
    • HECT domain and RCC1-like domain-containing protein 5 antibody
    • Hect domain and RLD 5 antibody
    • HECT E3 ubiquitin ligase antibody
    • HERC5 antibody
    • HERC5_HUMAN antibody
    • Herc6 antibody
    see all

Anti-HECT E3 ubiquitin ligase antibody images

  • Anti-HECT E3 ubiquitin ligase antibody (ab90146) at 1 µg/ml (in 5% skim milk / PBS buffer) + HT1080 cell lysate at 10 µg

    Secondary
    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 117 kDa

References for Anti-HECT E3 ubiquitin ligase antibody (ab90146)

ab90146 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab90146.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"